These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 22959118)

  • 21. [The role of the NMDA-receptor blocker and stimulator ketamine and glycine in the development of a neuropathic pain syndrome].
    Danilova EI; Grafova VN; Reshetniak VK
    Eksp Klin Farmakol; 1997; 60(4):10-3. PubMed ID: 9376747
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ketamine*.
    Quibell R; Prommer EE; Mihalyo M; Twycross R; Wilcock A
    J Pain Symptom Manage; 2011 Mar; 41(3):640-9. PubMed ID: 21419322
    [No Abstract]   [Full Text] [Related]  

  • 23. The promise of rapidly acting antidepressants: challenges and opportunities.
    Smith MA; Pathak S
    Biol Psychiatry; 2012 Aug; 72(4):252-3. PubMed ID: 22840946
    [No Abstract]   [Full Text] [Related]  

  • 24. [Effect of ketamine on cerebral circulation of intact and ischemic animals].
    Melkumian VS; Khaĭlov NA; Gaevyĭ MD
    Eksp Klin Farmakol; 2004; 67(1):15-8. PubMed ID: 15079901
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ketamine attenuates sympathetic activity through mechanisms not mediated by N-methyl-D-aspartate receptors in the isolated spinal cord of neonatal rats.
    Ho CM; Su CK
    Anesth Analg; 2006 Mar; 102(3):806-10. PubMed ID: 16492832
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The role of the glutamatergic system in pathophysiology and pharmacotherapy for depression: preclinical and clinical data].
    Paslakis G; Gass P; Deuschle M
    Fortschr Neurol Psychiatr; 2011 Apr; 79(4):204-12. PubMed ID: 21117011
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The vasodilatory effect of ketamine is independent of the N-methyl-D-aspartate receptor: lack of functional N-methyl-D-aspartate receptors in rat mesenteric artery smooth muscle.
    Noh HJ; Bae YM; Park SH; Kim JG; Kim B; Kim YS; Kim SH; Cho SI; Woo NS
    Eur J Anaesthesiol; 2009 Aug; 26(8):676-82. PubMed ID: 19352184
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Low dose ketamine: a therapeutic and research tool to explore N-methyl-D-aspartate (NMDA) receptor-mediated plasticity in pain pathways.
    Chizh BA
    J Psychopharmacol; 2007 May; 21(3):259-71. PubMed ID: 17591654
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prolonged analgesic effect of ketamine, an N-methyl-D-aspartate receptor inhibitor, in patients with chronic pain.
    Rabben T; Skjelbred P; Oye I
    J Pharmacol Exp Ther; 1999 May; 289(2):1060-6. PubMed ID: 10215688
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ketamine for the treatment of depression: what about the addictive potential?
    Hillemacher T; Bleich S; Demling J; Kornhuber J
    Aust N Z J Psychiatry; 2007 Sep; 41(9):772-3. PubMed ID: 17896416
    [No Abstract]   [Full Text] [Related]  

  • 31. Chronic administration of ketamine elicits antidepressant-like effects in rats without affecting hippocampal brain-derived neurotrophic factor protein levels.
    Garcia LS; Comim CM; Valvassori SS; Réus GZ; Andreazza AC; Stertz L; Fries GR; Gavioli EC; Kapczinski F; Quevedo J
    Basic Clin Pharmacol Toxicol; 2008 Dec; 103(6):502-6. PubMed ID: 19067677
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Electroconvulsive therapy-induced persistent retrograde amnesia: could it be minimised by ketamine or other pharmacological approaches?
    Gregory-Roberts EM; Naismith SL; Cullen KM; Hickie IB
    J Affect Disord; 2010 Oct; 126(1-2):39-45. PubMed ID: 20060172
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Terminating prolonged refractory status epilepticus using ketamine.
    Hsieh CY; Sung PS; Tsai JJ; Huang CW
    Clin Neuropharmacol; 2010 May; 33(3):165-7. PubMed ID: 20098301
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The use of ketamine in complex regional pain syndrome: possible mechanisms.
    Schwartzman RJ; Alexander GM; Grothusen JR
    Expert Rev Neurother; 2011 May; 11(5):719-34. PubMed ID: 21539489
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ketamine: a controversial drug for neonates.
    Bhutta AT
    Semin Perinatol; 2007 Oct; 31(5):303-8. PubMed ID: 17905185
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ketamine plus imipramine treatment induces antidepressant-like behavior and increases CREB and BDNF protein levels and PKA and PKC phosphorylation in rat brain.
    Réus GZ; Stringari RB; Ribeiro KF; Ferraro AK; Vitto MF; Cesconetto P; Souza CT; Quevedo J
    Behav Brain Res; 2011 Aug; 221(1):166-71. PubMed ID: 21397634
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Alterations of plasma and cerebrospinal fluid glutamate levels in rats treated with the N-methyl-D-aspartate receptor antagonist, ketamine.
    Tomiya M; Fukushima T; Kawai J; Aoyama C; Mitsuhashi S; Santa T; Imai K; Toyo'oka T
    Biomed Chromatogr; 2006; 20(6-7):628-33. PubMed ID: 16779778
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [ECT and antidepressive agents].
    Rosenberg R; Bolwig TG
    Ugeskr Laeger; 2000 Jan; 162(1):70-1. PubMed ID: 10658507
    [No Abstract]   [Full Text] [Related]  

  • 39. Menstrual cycle-related variations in postoperative analgesia with the preemptive use of N-methyl D-aspartate antagonist ketamine: a pilot study.
    Lenzmeier B; Moore RL; Cordts P; Garrett N
    Dimens Crit Care Nurs; 2008; 27(6):271-6. PubMed ID: 18953197
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of ketamine on sensory perception: evidence for a role of N-methyl-D-aspartate receptors.
    Oye I; Paulsen O; Maurset A
    J Pharmacol Exp Ther; 1992 Mar; 260(3):1209-13. PubMed ID: 1312163
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.